Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1CNS 1

Conditions

Sarcoma 1Neuroblastoma 1Lymphoma 1Dendritic Cell Sarcoma, Interdigitating 1Central Nervous System Neoplasms 1Burkitt Lymphoma 1

Interventions

Cyclophosphamide 7Etoposide 6fludarabine phosphate 5Methotrexate 5Filgrastim 5Vincristine 4Rituximab 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Antilymphocyte Serum 4Methylprednisolone 3Ifosfamide 3Doxorubicin 3Cytarabine 3Busulfan 3aldesleukin 2Vorinostat 2Prednisone 2Oxaliplatin 2Mycophenolic Acid 2Mercaptopurine 2Melphalan 2Dexamethasone 2Daunorubicin 2Cyclosporine 2Asparaginase 2trioctyl phosphine oxide 1sargramostim 1pevonedistat 1obatoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Dendritic Cell Sarcoma, Interdigitating × gallium nitrate × Clear all
NCT00002543 2013-07-18

Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors

National Cancer Institute (NCI)

Phase 1 Completed
3 enrolled
CNSLymphoidSarcoma

Burkitt Lymphoma, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡